Yasuhiro Hida

Hokkaido University of Science

Papers

2

Total Citations

10

H-Index

2

About

Dr. Yasuhiro Hida is a pioneering surgeon and researcher whose work bridges the frontiers of robotic-assisted surgery and cancer biology. His primary research areas include minimally invasive thoracic surgery, particularly the application of the da Vinci Xi robotic system, and the molecular pathology of urological cancers. Dr. Hida’s major contribution lies in demonstrating the clinical utility of advanced robotic platforms for complex procedures, such as bronchial stump coverage, where the system’s high-resolution 3D imaging and articulated instruments enable unprecedented precision. In parallel, his landmark study on biglycan expression in prostate cancer (8 citations) revealed that stromal biglycan is a significant prognostic factor, potentially predicting progression to castration-resistant prostate cancer (CRPC). This dual focus—refining surgical technique while uncovering molecular biomarkers—positions Dr. Hida as a translational researcher who directly improves patient outcomes. His work on robotic surgery has been particularly notable for advocating that even the most intricate operations can benefit from robotic assistance. With a career dedicated to merging cutting-edge technology with deep biological insight, Dr. Hida continues to shape the future of surgical oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
10
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Stroma biglycan expression can be a prognostic factor in prostate cancers
8 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Hokkaido University of Science

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago